Filippo Montemurro, Valentina Rossi, Maria Cossu Rocca, Rossella Martinello, Elena Verri, Stefania Redana, Laura Adamoli, Giorgio Valabrega, Anna Sapino, Massimo Aglietta, Giuseppe Viale, Aron Goldhirsch and Franco Nolè Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients Cancer 118
Version of Record online: 19 MAY 2011 | DOI: 10.1002/cncr.26162
The authors evaluated the predictive value of quantitative hormone receptor expression in patients with HER2-positive advanced breast cancer receiving trastuzumab and chemotherapy. Whereas high hormone receptor expression predicted reduced response rate, hormone receptor positivity was associated with a large progression-free survival benefit when endocrine therapy was added to trastuzumab after chemotherapy.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field